Senthil Vel Sundaram Terns Pharmaceuticals, Inc. (TERN) insider trading activity

Senthil Vel Sundaram is Chief Executive Officer of Terns Pharmaceuticals, Inc.. Currently has a direct ownership of 9,770 shares of TERN, which is worth approximately $67,803. The most recent transaction as insider was on May 31, 2023, when has been sold 2,111 shares (Common Stock) at a price of $1.41 per share, resulting in proceeds of $2,976. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.77K

0% 3M change

0% 12M change

Total Value Held $67,803

Senthil Vel Sundaram Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 31 2023	BUY Open market or private purchase	$2,976 $1.41 p/Share	2,111 Added 17.77%	9,770 Common Stock
Nov 30 2022	BUY Open market or private purchase	$4 $1.41 p/Share	3 Added 0.04%	7,659 Common Stock
May 31 2022	BUY Open market or private purchase	$11,254 $1.47 p/Share	7,656 Added 50.0%	7,656 Common Stock

Also insider at

SIOX

Sio Gene Therapies Inc. Healthcare

Director

SVS